Literature DB >> 22890910

Increased CSF concentrations of myelin basic protein after TBI in infants and children: absence of significant effect of therapeutic hypothermia.

E Su1, M J Bell, P M Kochanek, S R Wisniewski, H Bayir, R S B Clark, P D Adelson, E C Tyler-Kabara, K L Janesko-Feldman, R P Berger.   

Abstract

BACKGROUND: The objectives of this study were to determine effects of severe traumatic brain injury (TBI) on cerebrospinal fluid (CSF) concentrations of myelin basic protein (MBP) and to assess relationships between clinical variables and CSF MBP concentrations.
METHODS: We measured serial CSF MBP concentrations in children enrolled in a randomized controlled trial evaluating therapeutic hypothermia (TH) after severe pediatric TBI. Control CSF was obtained from children evaluated, but found not to be having CNS infection. Generalized estimating equation models and Wilcoxon Rank-Sum test were used for comparisons of MBP concentrations.
RESULTS: There were 27 TBI cases and 57 controls. Overall mean (± SEM) TBI case MBP concentrations for 5 days after injury were markedly greater than controls (50.49 ± 6.97 vs. 0.11 ± 0.01 ng/ml, p < 0.01). Mean MBP concentrations were lower in TBI patients <1 year versus >1 year (9.18 ± 1.67 vs. 60.22 ± 8.26 ng/ml, p = 0.03), as well as in cases with abusive head trauma (AHT) versus non-abusive TBI (14.46 ± 3.15 vs. 61.17 ± 8.65 ng/ml, p = 0.03). TH did not affect MBP concentrations.
CONCLUSIONS: Mean CSF MBP increases markedly after severe pediatric TBI, but is not affected by TH. Infancy and AHT are associated with low MBP concentrations, suggesting that age-dependent myelination influences MBP concentrations after injury. Given the magnitude of MBP increases, axonal injury likely represents an important therapeutic target in pediatric TBI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22890910      PMCID: PMC3836276          DOI: 10.1007/s12028-012-9767-0

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  28 in total

1.  Innate gender-based proclivity in response to cytotoxicity and programmed cell death pathway.

Authors:  Lina Du; Hülya Bayir; Yichen Lai; Xiaopeng Zhang; Patrick M Kochanek; Simon C Watkins; Steven H Graham; Robert S B Clark
Journal:  J Biol Chem       Date:  2004-07-01       Impact factor: 5.157

2.  Axonal cytoskeletal responses to nondisruptive axonal injury and the short-term effects of posttraumatic hypothermia.

Authors:  W L Maxwell; S Donnelly; X Sun; T Fenton; N Puri; D I Graham
Journal:  J Neurotrauma       Date:  1999-12       Impact factor: 5.269

3.  Phase II clinical trial of moderate hypothermia after severe traumatic brain injury in children.

Authors:  P David Adelson; John Ragheb; Paul Kanev; Douglas Brockmeyer; Sue R Beers; S Danielle Brown; Laura D Cassidy; Yuefang Chang; Harvey Levin
Journal:  Neurosurgery       Date:  2005-04       Impact factor: 4.654

4.  Serum-myelin-basic-protein assay in diagnosis and prognosis of patients with head injury.

Authors:  D G Thomas; J W Palfreyman; J G Ratcliffe
Journal:  Lancet       Date:  1978-01-21       Impact factor: 79.321

5.  Moderate posttraumatic hypothermia decreases early calpain-mediated proteolysis and concomitant cytoskeletal compromise in traumatic axonal injury.

Authors:  A Büki; H Koizumi; J T Povlishock
Journal:  Exp Neurol       Date:  1999-09       Impact factor: 5.330

Review 6.  Maturation of white matter in the human brain: a review of magnetic resonance studies.

Authors:  T Paus; D L Collins; A C Evans; G Leonard; B Pike; A Zijdenbos
Journal:  Brain Res Bull       Date:  2001-02       Impact factor: 4.077

7.  Cognitive sequelae of diffuse axonal injury.

Authors:  Rainer Scheid; Kathrin Walther; Thomas Guthke; Christoph Preul; D Yves von Cramon
Journal:  Arch Neurol       Date:  2006-03

8.  Window of opportunity of cerebral hypothermia for postischemic white matter injury in the near-term fetal sheep.

Authors:  Vincent Roelfsema; Laura Bennet; Sherly George; David Wu; Jian Guan; Marije Veerman; Alistair Jan Gunn
Journal:  J Cereb Blood Flow Metab       Date:  2004-08       Impact factor: 6.200

9.  Gender as a moderator of memory after traumatic brain injury in children.

Authors:  Jacobus Donders; Helen R Woodward
Journal:  J Head Trauma Rehabil       Date:  2003 Mar-Apr       Impact factor: 2.710

10.  Marked gender effect on lipid peroxidation after severe traumatic brain injury in adult patients.

Authors:  Hülya Bayir; Donald W Marion; Ava M Puccio; Stephen R Wisniewski; Keri L Janesko; Robert S B Clark; Patrick M Kochanek
Journal:  J Neurotrauma       Date:  2004-01       Impact factor: 5.269

View more
  19 in total

Review 1.  Fluid biomarkers for mild traumatic brain injury and related conditions.

Authors:  Henrik Zetterberg; Kaj Blennow
Journal:  Nat Rev Neurol       Date:  2016-09-16       Impact factor: 42.937

2.  Microwave & Magnetic (M2) Proteomics of a Mouse Model of Mild Traumatic Brain Injury.

Authors:  Teresa M Evans; Holly Van Remmen; Anjali Purkar; Swetha Mahesula; J Al Gelfond; Marian Sabia; Wenbo Qi; Ai-Ling Lin; Carlos A Jaramillo; William E Haskins
Journal:  Transl Proteom       Date:  2014-06-01

Review 3.  White matter damage after traumatic brain injury: A role for damage associated molecular patterns.

Authors:  Molly Braun; Kumar Vaibhav; Nancy M Saad; Sumbul Fatima; John R Vender; Babak Baban; Md Nasrul Hoda; Krishnan M Dhandapani
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-05-19       Impact factor: 5.187

Review 4.  Chapter 6 state of the science of pediatric traumatic brain injury: biomarkers and gene association studies.

Authors:  Karin Reuter-Rice; Julia K Eads; Suzanna Boyce Berndt; Ellen Bennett
Journal:  Annu Rev Nurs Res       Date:  2015

Review 5.  Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future.

Authors:  Itay Raphael; Johanna Webb; Olaf Stuve; William Haskins; Thomas Forsthuber
Journal:  Expert Rev Clin Immunol       Date:  2014-12-18       Impact factor: 4.473

Review 6.  Emerging therapies in traumatic brain injury.

Authors:  Patrick M Kochanek; Travis C Jackson; Nikki Miller Ferguson; Shaun W Carlson; Dennis W Simon; Erik C Brockman; Jing Ji; Hülya Bayır; Samuel M Poloyac; Amy K Wagner; Anthony E Kline; Philip E Empey; Robert S B Clark; Edwin K Jackson; C Edward Dixon
Journal:  Semin Neurol       Date:  2015-02-25       Impact factor: 3.420

Review 7.  Biomarkers in Moderate to Severe Pediatric Traumatic Brain Injury: A Review of the Literature.

Authors:  Jennifer C Munoz Pareja; Xue Li; Nithya Gandham; Kevin K Wang
Journal:  Pediatr Neurol       Date:  2022-03-18       Impact factor: 3.372

8.  Serum biomarkers of brain injury to classify outcome after pediatric cardiac arrest*.

Authors:  Ericka L Fink; Rachel P Berger; Robert S B Clark; Robert S Watson; Derek C Angus; Rudolph Richichi; Ashok Panigrahy; Clifton W Callaway; Michael J Bell; Patrick M Kochanek
Journal:  Crit Care Med       Date:  2014-03       Impact factor: 7.598

Review 9.  Glial biomarkers in human central nervous system disease.

Authors:  Gwenn A Garden; Brian M Campbell
Journal:  Glia       Date:  2016-05-26       Impact factor: 7.452

10.  Myelin basic protein and neurofilament H in postmortem cerebrospinal fluid as surrogate markers of fatal traumatic brain injury.

Authors:  Benjamin Ondruschka; Michael Bohnert; Simone Bohnert; Christoph Wirth; Werner Schmitz; Stefanie Trella; Camelia-Maria Monoranu
Journal:  Int J Legal Med       Date:  2021-04-24       Impact factor: 2.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.